Montalbano, John — Insider Profile

Insider Profile

Montalbano, John

🔒 Follow — get an alert on any new filing

$EPRX $MFC

Companies Filed At

Open-Market Buys (2yr)

$370K

Buy Value (2yr, open-market)

Jun 30, 2026

Most Recent Trade

Credibility
Score

50%

Hit Rate

+19.1%

Avg 90d Return

-1.3%

Median 90d Return

Evaluated Trades

+161.4%

Best Trade

-39.3%

Worst Trade

Hit rate and returns are based on 10 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

43%

Hit Rate · 90d

-12.0%

Median Alpha · 90d

Closed Buys Evaluated

43%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer high frequency size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 7 closed buys with individual return outcomes available on the Research plan.

Political Donations · Elections Canada

$5K in individual political contributions across 4 donations (2014–2014).

Date	Party	Recipient	Amount
2014-09-09	Liberal Party of Canada	Garneau, Marc	$1K
2014-09-09	Liberal Party of Canada	Liberal Party of Canada	$1K
2014-08-28	Liberal Party of Canada	Vancouver Granville Federal Liberal Association	$1K
2014-08-28	Liberal Party of Canada	Liberal Party of Canada	$1K

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Confluence Score input.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 30, 2026	$MFC Manulife Financial	—	Plan / DRIP	Buy	37	—	—	78
Jun 30, 2026	$MFC Manulife Financial	—	Other	Buy	844	—	—	78
Mar 31, 2026	$MFC Manulife Financial	—	Other	Buy	1,021	—	—	78
Mar 31, 2026	$MFC Manulife Financial	—	Plan / DRIP	Buy	34	—	—	78
Mar 09, 2026	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	21,875	$11.20	$245K	62
Feb 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	243,900	$3.00	$732K	62
Feb 02, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	243,900	$3.00	$732K	62
Dec 31, 2025	$MFC Manulife Financial	—	Other	Buy	871	—	—	78
Dec 31, 2025	$MFC Manulife Financial	—	Plan / DRIP	Buy	21	—	—	78
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	10,000	$8.63	$86K	62
Dec 15, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	10,000	$8.63	$86K	62
Nov 02, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	12,500	$8.00	$100K	62
Sep 30, 2025	$MFC Manulife Financial	—	Plan / DRIP	Buy	14	—	—	78
Sep 30, 2025	$MFC Manulife Financial	—	Other	Buy	1,029	—	—	78
Sep 24, 2025	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	67,273	$5.50	$370K	62
Mar 31, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	25,000	$8.00	$200K	62
Mar 31, 2025	$MFC Manulife Financial	—	Other	Buy	357	—	—	78
Mar 25, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	45,000	$5.14	$231K	62
Feb 28, 2025	$MFC Manulife Financial	—	Other	Sell	—	—	—	78
Feb 28, 2025	$MFC Manulife Financial	—	Other	Sell	—	—	—	78
Jun 28, 2024	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	14,800	$3.50	$52K	62
May 13, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	45,000	$3.96	$178K	62
Jan 04, 2024	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	39,846	$7.20	$287K	62
Aug 18, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Sell	75,000	$7.00	$525K	62
Dec 16, 2022	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	22,006	$8.00	$176K	62
Sep 07, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	4,500	$1.50	$7K	62
Sep 06, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	1,600	$1.50	$2K	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	37,500	$8.00	$300K	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	21,875	$0.00	$44	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Corp. Event	Buy	122,595	$8.00	$981K	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	43,750	$8.00	$350K	62

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.